George Harrison Talbot's Net Worth
$50.4 Thousand
Who is George Harrison Talbot?
George Harrison Talbot does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Nabriva Therapeutics AG, and Durata Therapeutics, Inc..
SEC CIK
George Harrison Talbot's CIK is 0001554194
Past Insider Trading and Trends
2017 was George Harrison Talbot's most active year for acquiring shares with 8 total transactions. George Harrison Talbot's most active month to acquire stocks was the month of June. 2017 was George Harrison Talbot's most active year for disposing of shares, totalling 15 transactions. George Harrison Talbot's most active month to dispose stocks was the month of April. 2018 saw George Harrison Talbot paying a total of $39,875.00 for 43,500 shares, this is the most they've acquired in one year. In 2017 George Harrison Talbot cashed out on 3,490 shares for a total of $90,276.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nabriva Therapeutics Plc No price found
InvestorGeorge Harrison Talbot owns 31,790 units of Ordinary Shares. In the year 2017 George Harrison Talbot filed a total of 1 filing.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 31.79K |
—
|
—
| 31.79K |
Jun 23
| |||
No matching records found |
Nabriva Therapeutics AG (NBRVF) Snapshot price: $0.000001
InvestorGeorge Harrison Talbot owns 3,179 units of Common Shares which is worth $0.00 and 65,140 units of Ordinary Shares which is worth $0.07. In the year 2016 George Harrison Talbot acquired a total of 34,585 shares in Nabriva Therapeutics AG at a cost of $39,875.00, George also disposed a total of 905 shares of Nabriva Therapeutics AG equalling to $90,276.90.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +36.73% | 17.5K |
—
|
—
| 65.14K |
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
| +43.75% | 14.5K |
$2.75 | $39,875.00 | 47.64K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
| +4.25% | 1.35K |
—
|
—
| 33.14K |
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
| -5.08% | -170.00 |
$93.18 | -$15,840.00 | 3.18K |
Jun 15 - Jun 19
| |||
Form 4
| -5.90% | -210.00 |
$101.26 | -$21,265.00 | 3.35K |
May 30
| |||
Form 4
| -8.37% | -325.00 |
$100.56 | -$32,683.50 | 3.56K |
May 23 - May 25
| |||
Form 4
| +36.33% | 1.03K |
$102.44 | -$20,488.40 | 3.88K |
Feb 16 - May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Durata Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |